Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

FlavoRx

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Albertson's Jewel-Osco division now offering OTC and Rx drug flavoring additive in 225 Midwest pharmacies, Melrose Park, Ill. based-firm announces April 4. FlavoRx now sells eponymous product in more than 3,500 pharmacies, including CVS, Giant, Kroger and Pathmark chains, and expects to break 5,000 stores by August. Firm also operates in Canada, U.K., Australia, New Zealand and the Bahamas (1"The Tan Sheet" Nov. 1, 1999, p. 12). FlavoRx plans to continue regionally targeted TV campaigns begun last year and doctor detailing to support brand in new markets

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Experts Urge Action On Regulatory Science Collaboration In Korea

Cancer Trials: FDA Wants Lower Performance Status Eligibility But Primary Analysis Exclusion OK

US FDA's Califf Defends Agency Work On Marijuana Rescheduling, Animal Testing

Overall Survival Is Not A Required Primary Endpoint In All Cancer Trials, US FDA Says

See All
UsernamePublicRestriction

Register

PS092396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By